These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10139487)

  • 1. Health care technology as a policy issue.
    Banta HD
    Health Policy; 1994; 30(1-3):1-21. PubMed ID: 10139487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from the eight countries.
    Battista RN; Banta HD; Jonnson E; Hodge M; Gelband H
    Health Policy; 1994; 30(1-3):397-421. PubMed ID: 10139496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special issue: Health care technology and its assessment in eight countries: Australia, Canada, France, Germany, Netherlands, Sweden, United Kingdom, United States.
    Health Policy; 1994; 30(1-3):1-421. PubMed ID: 10139488
    [No Abstract]   [Full Text] [Related]  

  • 4. The development of health care technology assessment. An international perspective.
    Battista RN; Hodge MJ
    Int J Technol Assess Health Care; 1995; 11(2):287-300. PubMed ID: 7790172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care technology in France.
    Weill C
    Health Policy; 1994; 30(1-3):123-62. PubMed ID: 10139489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care expenditures in nine industrialized countries, 1960-76.
    Simanis JG; Coleman JR
    Soc Secur Bull; 1980 Jan; 43(1):3-8. PubMed ID: 6769168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing medical technology: lessons for the United States from Quebec and France.
    Rosenau PV
    Int J Health Serv; 2000; 30(3):617-39. PubMed ID: 11109185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care cost containment strategies used in four other high-income countries hold lessons for the United States.
    Stabile M; Thomson S; Allin S; Boyle S; Busse R; Chevreul K; Marchildon G; Mossialos E
    Health Aff (Millwood); 2013 Apr; 32(4):643-52. PubMed ID: 23569043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment of cancer drugs in Canada, the United Kingdom and Australia: should the United States take notice?
    Dranitsaris G; Papadopoulos G
    Appl Health Econ Health Policy; 2015 Jun; 13(3):291-302. PubMed ID: 25274258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles.
    Rand LZ; Kesselheim AS
    J Law Med Ethics; 2020 Sep; 48(3):583-594. PubMed ID: 33021189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care technology in Sweden.
    Jonsson E; Banta HD
    Health Policy; 1994; 30(1-3):257-94. PubMed ID: 10139493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International diffusion of new health technologies: a ten-country analysis of six health technologies.
    Packer C; Simpson S; Stevens A;
    Int J Technol Assess Health Care; 2006; 22(4):419-28. PubMed ID: 16984674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care technology in Canada (with special reference to Quebec).
    Battista RN; Jacob R; Hodge MJ
    Health Policy; 1994; 30(1-3):73-122. PubMed ID: 10139497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care technology in Australia.
    Hailey D
    Health Policy; 1994; 30(1-3):23-72. PubMed ID: 10139492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers.
    Banta HD; Vondeling H
    Soc Sci Med; 1994 Jun; 38(12):1663-74. PubMed ID: 8047925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care technology in The Netherlands.
    Bos M
    Health Policy; 1994; 30(1-3):207-55. PubMed ID: 10139491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical industry's perspective on health technology assessment.
    Lothgren M; Ratcliffe M
    Int J Technol Assess Health Care; 2004; 20(1):97-101. PubMed ID: 15176185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and diffusion of excimer laser treatment of myopia in the United States and in The Netherlands.
    Vondeling H; Rosendal H; Banta D
    Health Policy; 1995 Oct; 34(1):21-33. PubMed ID: 10151963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.